(E) -Tadehaginoside
(E) -Tadehaginoside is the E-isomer of Tadehaginoside. Tadehaginoside, a phenylpropanoid glycoside, is a regulator of lipogenesis and glucose consumption. Tadehaginoside has antioxygenic property. Tadehaginoside mediates liver protection against oxidative stress injury and inflammation by regulating Nrf2 and NF-κB signaling pathways in hepatocytes. Tadehaginoside can be used for the study of obesity and diabetes[1][2].
Product Specifications
CAS Number
283176-41-0
UNSPSC
12352005
Target
Keap1-Nrf2; NF-κB
Related Pathways
NF-κB
Field of Research
Metabolic Disease; Inflammation/Immunology
Smiles
OC(C=C1)=CC=C1/C=C/C(OC[C@H]([C@H]([C@@H]([C@H]2O)O)O)O[C@H]2OC3=CC(O)=CC(O)=C3)=O
Molecular Formula
C21H22O10
Molecular Weight
434.39
References & Citations
[1]Tang A, et al. Antihepatotoxic effect of tadehaginoside, extracted from Tadehagi triquetrum (L.), against CCl4-lesioned rats through activating the Nrf2 signaling pathway and attenuating the inflammatory response. Inflammation. 2014 Aug;37 (4) :1006-14.|[2]Zhang X, et al. Tadehaginoside modulates lipogenesis and glucose consumption in HepG2 cells. Nat Prod Res. 2015;29 (24) :2287-90.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KN205162 1 Kit
Angiotensin II Type 1 Receptor (AGTR1) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
BNC882001-100 1x 100 µL
IL-10R1, Mouse (Interleukin-10 Receptor 1) (CD210) (1B1.3a), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940688-100 1x 100 µL
Cytokeratin 8 (C-43), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 